These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27422086)

  • 21. Simulation of Unit Operations in Formulation Development of Tablets Using Computational Fluid Dynamics.
    Hemamanjushree S; Tippavajhala VK
    AAPS PharmSciTech; 2020 Mar; 21(3):103. PubMed ID: 32166477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering tools for understanding the hydrodynamics of dissolution tests.
    Kukura J; Arratia PE; Szalai ES; Muzzio FJ
    Drug Dev Ind Pharm; 2003 Feb; 29(2):231-9. PubMed ID: 12648020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new method for disintegration studies of rapid disintegrating tablet.
    Narazaki R; Harada T; Takami N; Kato Y; Ohwaki T
    Chem Pharm Bull (Tokyo); 2004 Jun; 52(6):704-7. PubMed ID: 15187391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.
    Uebbing L; Klumpp L; Webster GK; Löbenberg R
    Drug Des Devel Ther; 2017; 11():1163-1174. PubMed ID: 28442890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biorelevant in-vitro performance testing of orally administered dosage forms.
    Reppas C; Vertzoni M
    J Pharm Pharmacol; 2012 Jul; 64(7):919-30. PubMed ID: 22686340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disintegration testing augmented by computer Vision technology.
    Floryanzia S; Ramesh P; Mills M; Kulkarni S; Chen G; Shah P; Lavrich D
    Int J Pharm; 2022 May; 619():121668. PubMed ID: 35304245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
    Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P
    Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability.
    D'Arcy DM; Corrigan OI; Healy AM
    J Pharm Pharmacol; 2005 Oct; 57(10):1243-50. PubMed ID: 16259752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the Hydrodynamics in the USP Basket Apparatus Using Computational Fluid Dynamics.
    Martinez AF; Sinha K; Nere N; Slade R; Castleberry S
    J Pharm Sci; 2020 Mar; 109(3):1231-1241. PubMed ID: 31743682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
    Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
    Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
    Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
    Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA; Augsburger LL
    Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrodynamics-induced variability in the USP apparatus II dissolution test.
    Baxter JL; Kukura J; Muzzio FJ
    Int J Pharm; 2005 Mar; 292(1-2):17-28. PubMed ID: 15725550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in numerical simulation of unit operations for tablet preparation.
    Li Z; Peng WH; Liu WJ; Yang LY; Naeem A; Feng Y; Ming LS; Zhu WF
    Int J Pharm; 2023 Mar; 634():122638. PubMed ID: 36702386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of tablet characteristics from residual stress distribution estimated by the finite element method.
    Hayashi Y; Miura T; Shimada T; Onuki Y; Obata Y; Takayama K
    J Pharm Sci; 2013 Oct; 102(10):3678-86. PubMed ID: 23897300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutics, Drug Delivery and Pharmaceutical Technology: A New Test Unit for Disintegration End-Point Determination of Orodispersible Films.
    Low A; Kok SL; Khong Y; Chan SY; Gokhale R
    J Pharm Sci; 2015 Nov; 104(11):3893-903. PubMed ID: 27524687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach.
    Otsuka K; Wagner C; Selen A; Dressman J
    J Pharm Pharmacol; 2015 May; 67(5):651-65. PubMed ID: 25644429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.